ID
INVG
Investing
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.
Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.
Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.
The investment will accelerate Nexus IT’s U.S. expansion and support acquisitions of culturally aligned MSPs in healthcare and other regulated industries.
The two organizations will collaborate to accelerate the company's growth and enhance proactive care and management of chronic diseases.